Maintaining genomic surveillance using whole-genome sequencing of SARS-CoV-2 from rapid antigen test devices.
作者信息
Martin Genevieve E, Taiaroa George, Taouk Mona L, Savic Ivana, O'Keefe Jacinta, Quach Robert, Prestedge Jacqueline, Krysiak Marcelina, Caly Leon, Williamson Deborah A
机构信息
Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia.
Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
出版信息
Lancet Infect Dis. 2022 Oct;22(10):1417-1418. doi: 10.1016/S1473-3099(22)00512-6. Epub 2022 Aug 4.
Abstract
摘要
相似文献
1
Maintaining genomic surveillance using whole-genome sequencing of SARS-CoV-2 from rapid antigen test devices.利用快速抗原检测设备对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进行全基因组测序，以维持基因组监测。
Lancet Infect Dis. 2022 Oct;22(10):1417-1418. doi: 10.1016/S1473-3099(22)00512-6. Epub 2022 Aug 4.
2
Inactivation and Recovery of High Quality RNA From Positive SARS-CoV-2 Rapid Antigen Tests Suitable for Whole Virus Genome Sequencing.从适合全病毒基因组测序的 SARS-CoV-2 快速抗原检测阳性样本中提取和恢复高质量 RNA
Front Public Health. 2022 May 3;10:863862. doi: 10.3389/fpubh.2022.863862. eCollection 2022.
3
Sequencing SARS-CoV-2 from antigen tests.对抗原检测进行 SARS-CoV-2 测序。
PLoS One. 2022 Feb 8;17(2):e0263794. doi: 10.1371/journal.pone.0263794. eCollection 2022.
4
High-precision and cost-efficient sequencing for real-time COVID-19 surveillance.实时 COVID-19 监测的高精度、低成本测序。
Sci Rep. 2021 Jul 1;11(1):13669. doi: 10.1038/s41598-021-93145-4.
5
CLIMB-COVID: continuous integration supporting decentralised sequencing for SARS-CoV-2 genomic surveillance.CLIMB-COVID：支持 SARS-CoV-2 基因组监测的去中心化测序的持续集成。
Genome Biol. 2021 Jul 1;22(1):196. doi: 10.1186/s13059-021-02395-y.
6
A deletion in the N gene may cause diagnostic escape in SARS-CoV-2 samples.N 基因缺失可能导致 SARS-CoV-2 样本的诊断逃逸。
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115540. doi: 10.1016/j.diagmicrobio.2021.115540. Epub 2021 Sep 17.
7
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.纳米孔测序快速分析 SARS-CoV-2 基因组的分析有效性。
Nat Commun. 2020 Dec 9;11(1):6272. doi: 10.1038/s41467-020-20075-6.
8
Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.两步策略测序揭示突尼斯高传播期后 SARS-CoV-2 S 基因的高遗传多样性。
Microbiol Spectr. 2021 Dec 22;9(3):e0063921. doi: 10.1128/Spectrum.00639-21. Epub 2021 Nov 10.
9
Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing.通过全基因组测序证实同时感染奥密克戎（B.1.1.529）和德尔塔（21A/478K.V1）变异株的 SARS-CoV-2。
Int J Infect Dis. 2022 Nov;124:104-106. doi: 10.1016/j.ijid.2022.09.002. Epub 2022 Sep 8.
10
Genomic surveillance of SARS-CoV-2 in the Republic of Congo.刚果共和国新型冠状病毒的基因组监测。
Int J Infect Dis. 2021 Apr;105:735-738. doi: 10.1016/j.ijid.2021.03.036. Epub 2021 Mar 15.
引用本文的文献
1
SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA.美国威斯康星州社区分发的快速抗原检测中的新冠病毒基因组监测
Emerg Infect Dis. 2025 May;31(13):61-69. doi: 10.3201/eid3113.241192.
2
Respiratory Virus Detection and Sequencing from SARS-CoV-2-Negative Rapid Antigen Tests.从新冠病毒2型阴性快速抗原检测中进行呼吸道病毒检测和测序
Emerg Infect Dis. 2025 May;31(13):39-44. doi: 10.3201/eid3113.241191.
3
Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）主要蛋白酶（Mpro）的靶向蛋白降解剂比单独的酶抑制更具活性，且对奈玛特韦耐药病毒具有活性。
Commun Med (Lond). 2025 Apr 26;5(1):140. doi: 10.1038/s43856-025-00863-1.
4
Whole-genome sequencing of SARS-CoV-2 from residual viral RNA present on positive rapid antigen test kits for genomic surveillance.对用于基因组监测的阳性快速抗原检测试剂盒上残留病毒RNA中的严重急性呼吸综合征冠状病毒2进行全基因组测序。
Western Pac Surveill Response J. 2025 Mar 31;16(1):1-6. doi: 10.5365/wpsar.2025.16.1.1140. eCollection 2025 Jan-Mar.
5
Exploring SNP filtering strategies: the influence of strict vs soft core.探索单核苷酸多态性（SNP）过滤策略：严格核心与软核心的影响。
Microb Genom. 2025 Jan;11(1). doi: 10.1099/mgen.0.001346.
6
Respiratory virus detection and sequencing from negative SARS-CoV-2 rapid antigen tests.从新冠病毒2型（SARS-CoV-2）快速抗原检测阴性样本中进行呼吸道病毒检测与测序
medRxiv. 2024 Aug 20:2024.08.19.24311993. doi: 10.1101/2024.08.19.24311993.
7
Optimisation and evaluation of viral genomic sequencing of SARS-CoV-2 rapid diagnostic tests: a laboratory and cohort-based study.SARS-CoV-2 快速诊断检测病毒基因组测序的优化和评估：一项基于实验室和队列的研究。
Lancet Microbe. 2024 May;5(5):e468-e477. doi: 10.1016/S2666-5247(23)00399-3. Epub 2024 Apr 12.
8
Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains.重新利用快速诊断测试来检测供应链中的伪造疫苗。
Vaccine. 2024 Mar 7;42(7):1506-1511. doi: 10.1016/j.vaccine.2024.01.019. Epub 2024 Feb 14.
9
SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests.使用 BinaxNOW COVID-19 抗原自测后从已用拭子中回收 RNA 进行 SARS-CoV-2 分子检测和全基因组测序。
J Clin Virol. 2023 May;162:105426. doi: 10.1016/j.jcv.2023.105426. Epub 2023 Mar 24.
10
Sequencing directly from antigen-detection rapid diagnostic tests in Belgium, 2022: a gamechanger in genomic surveillance?2022 年在比利时直接对抗原检测快速诊断检测进行测序：这是基因组监测的一个重大变化吗？
Euro Surveill. 2023 Mar;28(9). doi: 10.2807/1560-7917.ES.2023.28.9.2200618.
Zotero 插件